HER Connection Support Line: 866.449.HER2

Have questions about HER2+ breast cancer? Get expert answers from registered oncology nurses at the HER Connection Support Line. Call 866.449.HER2 (8AM-8PM ET)

HER connection Herceptin patient

Discover HER connection
A program designed to support you with knowledge and information about HER2+ breast cancer.

Sign up for HER connection

Join Team HER2

Sponsored by: Genentech BioOncology TEAM HER2, launched by Genentech BioOncology in 2009, is the first-ever national walk team dedicated to patients and caregivers affected by HER2-positive breast cancer. TEAM HER2 offers women and caregivers impacted by this diagnosis the opportunity to connect with others within their communities to exchange support and provide motivation.

As an official sponsor of the 2009 Avon Walk for Breast Cancer, Genentech is coordinating TEAM HER2 teams in each of the nine Avon Walk for Breast Cancer events. Everyone affected by HER2-positive breast cancer is invited to join TEAM HER2 to walk in the fight against breast cancer.

The Avon Walk for Breast Cancer is a two-day, 39-mile fundraising walk. By participating in the Avon Walk, you’re helping to raise funds to assist medically under-insured women and men to receive the screening, support, and treatment they require. And leading-edge research teams from around the country will be provided with the funds they need to fuel their quest for a cure.

Interested individuals must first register for the 2009 Avon Walk for Breast Cancer. Once registered for the Avon Walk, click here to receive a TEAM HER2 application. Avon Walk registration fee and fundraising requirement is the responsibility of the participant.

So, put on your walking shoes, show your support and meet others impacted by HER2-positive breast cancer. Take the first step and join today.

2009 Avon Walk for Breast Cancer Events:

Dates City
April 4-5 Houston, TX Register
May 2-3 Washington, D.C. Register
May 16-17 Boston, MA Register
June 6-7 Chicago, IL Register
June 27-28 Rocky Mountains, CO Register
July 11-12 San Francisco, CA Register
Sept. 12-13 Los Angeles, CA Register
October 10-11 New York, NY Register
October 24-25 Charlotte, NC Register


Herceptin® (trastuzumab)Herceptin® (trastuzumab)

Adjuvant Care Is defined as additional treatment given after the main treatment plan to decrease the chance of recurrence. Adjuvant therapy for breast cancer can include chemotherapy, hormone therapy, radiation therapy, or biological therapy

Metastatic Breast Cancer Breast cancer that has spread to other sites in the body; also referred to as invasive or infiltrating

close

Share this page


Email this page